Public Health/Global Health
Poster Session 1
Alla Saban, MD, MPH
Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Beer Sheva, HaDarom, Israel, Israel
Yael Reicher, MD (she/her/hers)
Soroka University Medical Center
Givat shmuel, HaMerkaz, Israel
Noa Leybovitz-Haleluya, MD (she/her/hers)
OB/Gyn resident
Soroka University Medical Center
Meitar, HaDarom, Israel
Lior Yahav, MD, MPH
Soroka Medical Center
Beer-Sheva, HaDarom, Israel
Adi Y. Weintraub, MD
Soroka Medical Center
Beer-Sheva, HaDarom, Israel
Reli Hershkovitz, MD
Head of the Obstretics and Gynecology Division
Soroka Medical Center
Omer, HaDarom, Israel
Tamar Eshkoli, MD
Senior
Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Beer Sheva, HaDarom, Israel, Israel
Coronavirus disease 2019 (COVID-19) infection posed elevated risks of severe illness and adverse obstetrical outcomes for pregnant women. Limited data is available regarding women who have been vaccinated but remained uninfected. Therefore, our study aimed to compare demographic and clinical characteristics of vaccinated and unvaccinated pregnant women without COVID19 infection during the peripartum period.
We conducted a population-based study at a tertiary medical center, enrolling all women with singleton pregnancies who delivered between 2020 and 2022 and were uninfected with COVID-19. Exclusion criteria included women with incomplete medical records, multiple gestations, and fetal malformations. The study group consisted of women who had received the COVID-19 vaccine, the comparison group consisted of women who had not been vaccinated. We studied the differences in demographic and obstetrical characteristics between both groups. Women with peripartum infection with COVID-19 were excluded.
In the vaccinated group, there was a significantly greater proportion of women aged 35 and above, as well as those of Jewish ethnicity. Additionally, pregnant women who received the COVID-19 vaccination demonstrated a notable increase in the use of epidural anesthesia.